Zynerba Pharmaceuticals, Inc. 0M40.L Stock
Zynerba Pharmaceuticals, Inc. Price Chart
Zynerba Pharmaceuticals, Inc. 0M40.L Financial and Trading Overview
| Zynerba Pharmaceuticals, Inc. stock price | 1.31 USD |
| Previous Close | 0.35 USD |
| Open | 0 USD |
| Bid | 0 USD x N/A |
| Ask | 0 USD x N/A |
| Day's Range | 0 - 0 USD |
| 52 Week Range | 0 - 1.37 USD |
| Volume | 24.7K USD |
| Avg. Volume | 2.29K USD |
| Market Cap | 131.48K USD |
| Beta (5Y Monthly) | 1.728169 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
0M40.L Valuation Measures
| Enterprise Value | -26376130 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.44929397 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.72 |
Trading Information
Zynerba Pharmaceuticals, Inc. Stock Price History
| Beta (5Y Monthly) | 1.728169 |
| 52-Week Change | -68.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.37 USD |
| 52 Week Low | 0 USD |
| 50-Day Moving Average | 0.41 USD |
| 200-Day Moving Average | 0.73 USD |
0M40.L Share Statistics
| Avg. Volume (3 month) | 2.29K USD |
| Avg. Daily Volume (10-Days) | 5.77K USD |
| Shares Outstanding | 17.62M |
| Float | 46.97M |
| Short Ratio | N/A |
| % Held by Insiders | 5.56% |
| % Held by Institutions | 13.52% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.41% |
| Return on Equity (ttm) | -70.40% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -36608576 USD |
| Net Income Avi to Common (ttm) | -36659032 USD |
| Diluted EPS (ttm) | -0.962 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 44.4M USD |
| Total Cash Per Share (mrq) | 0.89 USD |
| Total Debt (mrq) | 276.35K USD |
| Total Debt/Equity (mrq) | 0.71 USD |
| Current Ratio (mrq) | 4.951 |
| Book Value Per Share (mrq) | 0.779 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -31107870 USD |
| Levered Free Cash Flow (ttm) | -17957198 USD |
Profile of Zynerba Pharmaceuticals, Inc.
| Country | United Kingdom |
| State | PA |
| City | Devon |
| Address | 80 West Lancaster Avenue |
| ZIP | 19333 |
| Phone | 484 581 7505 |
| Website | https://www.zynerba.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 25 |
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Q&A For Zynerba Pharmaceuticals, Inc. Stock
What is a current 0M40.L stock price?
Zynerba Pharmaceuticals, Inc. 0M40.L stock price today per share is 1.31 USD.
How to purchase Zynerba Pharmaceuticals, Inc. stock?
You can buy 0M40.L shares on the LSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zynerba Pharmaceuticals, Inc.?
The stock symbol or ticker of Zynerba Pharmaceuticals, Inc. is 0M40.L.
How many shares does Zynerba Pharmaceuticals, Inc. have in circulation?
The max supply of Zynerba Pharmaceuticals, Inc. shares is 375.65K.
What is Zynerba Pharmaceuticals, Inc. Price to Earnings Ratio (PE Ratio)?
Zynerba Pharmaceuticals, Inc. PE Ratio is 0.00000000 now.
What was Zynerba Pharmaceuticals, Inc. earnings per share over the trailing 12 months (TTM)?
Zynerba Pharmaceuticals, Inc. EPS is 0 USD over the trailing 12 months.